MEDINET Co., Ltd. (2370.T)
JPY 37.0
(0.0%)
JPY 37.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 67.48 Million JPY | 36.27% |
| 2022 | 49.51 Million JPY | 18.27% |
| 2021 | 41.87 Million JPY | -16.35% |
| 2020 | 50.05 Million JPY | -9.37% |
| 2019 | 55.22 Million JPY | 13.63% |
| 2018 | 48.6 Million JPY | 8.2% |
| 2017 | 44.91 Million JPY | -25.65% |
| 2016 | 60.41 Million JPY | -38.62% |
| 2015 | 98.43 Million JPY | -4.46% |
| 2014 | 103.02 Million JPY | -9.73% |
| 2013 | 114.12 Million JPY | -13.27% |
| 2012 | 131.58 Million JPY | -0.68% |
| 2011 | 132.48 Million JPY | 336.5% |
| 2010 | 30.35 Million JPY | 34.47% |
| 2009 | 22.57 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 50.27 Million JPY | -3.12% |
| 2024 Q1 | 48.9 Million JPY | -27.53% |
| 2024 Q2 | 51.89 Million JPY | 6.11% |
| 2023 Q2 | 54.49 Million JPY | 6.84% |
| 2023 Q3 | 56.96 Million JPY | 4.52% |
| 2023 Q4 | 67.48 Million JPY | 18.47% |
| 2023 Q1 | 51 Million JPY | 3.0% |
| 2023 FY | 67.48 Million JPY | 36.27% |
| 2022 Q1 | 36.57 Million JPY | -12.65% |
| 2022 FY | 49.51 Million JPY | 18.27% |
| 2022 Q4 | 49.51 Million JPY | 14.09% |
| 2022 Q3 | 43.4 Million JPY | 9.85% |
| 2022 Q2 | 39.51 Million JPY | 8.02% |
| 2021 Q1 | 55.77 Million JPY | 11.43% |
| 2021 FY | 41.87 Million JPY | -16.35% |
| 2021 Q4 | 41.87 Million JPY | 3.28% |
| 2021 Q3 | 40.54 Million JPY | -40.95% |
| 2021 Q2 | 68.65 Million JPY | 23.09% |
| 2020 Q4 | 50.05 Million JPY | 14.06% |
| 2020 FY | 50.05 Million JPY | -9.37% |
| 2020 Q2 | 46.92 Million JPY | -7.56% |
| 2020 Q3 | 43.88 Million JPY | -6.48% |
| 2020 Q1 | 50.76 Million JPY | -8.08% |
| 2019 Q1 | 48.62 Million JPY | 0.03% |
| 2019 Q4 | 55.22 Million JPY | 17.47% |
| 2019 Q3 | 47.01 Million JPY | -4.32% |
| 2019 Q2 | 49.13 Million JPY | 1.06% |
| 2019 FY | 55.22 Million JPY | 13.63% |
| 2018 Q4 | 48.6 Million JPY | 17.67% |
| 2018 Q3 | 41.3 Million JPY | 6.95% |
| 2018 Q2 | 38.62 Million JPY | -17.87% |
| 2018 Q1 | 47.02 Million JPY | 4.69% |
| 2018 FY | 48.6 Million JPY | 8.2% |
| 2017 Q4 | 44.91 Million JPY | -9.78% |
| 2017 Q2 | 52.18 Million JPY | -14.52% |
| 2017 Q3 | 49.78 Million JPY | -4.6% |
| 2017 FY | 44.91 Million JPY | -25.65% |
| 2017 Q1 | 61.05 Million JPY | 1.05% |
| 2016 Q1 | 90.41 Million JPY | -8.15% |
| 2016 Q2 | 79.55 Million JPY | -12.01% |
| 2016 Q3 | 73.9 Million JPY | -7.11% |
| 2016 Q4 | 60.41 Million JPY | -18.25% |
| 2016 FY | 60.41 Million JPY | -38.62% |
| 2015 FY | 98.43 Million JPY | -4.46% |
| 2015 Q2 | 94.37 Million JPY | -4.67% |
| 2015 Q1 | 98.99 Million JPY | -3.9% |
| 2015 Q4 | 98.43 Million JPY | 5.22% |
| 2015 Q3 | 93.54 Million JPY | -0.88% |
| 2014 Q3 | 106.99 Million JPY | -2.43% |
| 2014 Q2 | 109.66 Million JPY | -4.22% |
| 2014 Q1 | 114.49 Million JPY | 0.32% |
| 2014 FY | 103.02 Million JPY | -9.73% |
| 2014 Q4 | 103.02 Million JPY | -3.71% |
| 2013 Q2 | 119.21 Million JPY | -9.37% |
| 2013 Q3 | 117.83 Million JPY | -1.16% |
| 2013 Q4 | 114.12 Million JPY | -3.15% |
| 2013 FY | 114.12 Million JPY | -13.27% |
| 2013 Q1 | 131.53 Million JPY | -0.04% |
| 2012 Q3 | 119.85 Million JPY | -0.29% |
| 2012 Q4 | 131.58 Million JPY | 9.78% |
| 2012 FY | 131.58 Million JPY | -0.68% |
| 2012 Q1 | 122.98 Million JPY | -7.17% |
| 2012 Q2 | 120.2 Million JPY | -2.26% |
| 2011 FY | 132.48 Million JPY | 336.5% |
| 2011 Q1 | 49.42 Million JPY | 62.85% |
| 2011 Q2 | 103.95 Million JPY | 110.32% |
| 2011 Q3 | 121.51 Million JPY | 16.89% |
| 2011 Q4 | 132.48 Million JPY | 9.03% |
| 2010 Q1 | 25.94 Million JPY | 14.96% |
| 2010 Q2 | 17.26 Million JPY | -33.45% |
| 2010 FY | 30.35 Million JPY | 34.47% |
| 2010 Q4 | 30.35 Million JPY | 51.32% |
| 2010 Q3 | 20.05 Million JPY | 16.14% |
| 2009 FY | 22.57 Million JPY | 0.0% |
| 2009 Q2 | 15.82 Million JPY | 9.66% |
| 2009 Q4 | 22.57 Million JPY | 0.0% |
| 2009 Q1 | 14.42 Million JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 90.12% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -276.379% |
| GNI Group Ltd. | 2.33 Billion JPY | 97.105% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 96.971% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 93.98% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | 34.822% |
| AnGes, Inc. | 1.61 Billion JPY | 95.824% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | 8.808% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 97.675% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 79.038% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -36574.457% |
| Carna Biosciences, Inc. | 140.14 Million JPY | 51.847% |
| CanBas Co., Ltd. | 728 Thousand JPY | -9169.368% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | 23.197% |
| RaQualia Pharma Inc. | 147.93 Million JPY | 54.386% |
| Chiome Bioscience Inc. | 64.1 Million JPY | -5.263% |
| Kidswell Bio Corporation | 875.65 Million JPY | 92.294% |
| PeptiDream Inc. | 2.4 Billion JPY | 97.193% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -1163.216% |
| Ribomic Inc. | 2.27 Million JPY | -2867.502% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -6748099900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -87.447% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -132.693% |
| CellSource Co., Ltd. | 305.92 Million JPY | 77.942% |
| FunPep Company Limited | 25.54 Million JPY | -164.207% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 81.464% |
| Stella Pharma Corporation | 1.11 Billion JPY | 93.955% |
| TMS Co., Ltd. | 50.02 Million JPY | -34.895% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -222.86% |
| Cuorips Inc. | 1.04 Million JPY | -6369.895% |
| K Pharma,Inc. | 10.79 Million JPY | -525.171% |
| Takara Bio Inc. | 11.85 Billion JPY | 99.431% |
| ReproCELL Incorporated | 248.14 Million JPY | 72.805% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 85.024% |
| StemCell Institute Inc. | 42.26 Million JPY | -59.673% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 70.476% |
| CellSeed Inc. | 46.19 Million JPY | -46.091% |